{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:42:08Z","timestamp":1771486928585,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.modpat.2023.100170","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T04:14:33Z","timestamp":1680063273000},"page":"100170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-9168","authenticated-orcid":false,"given":"Stephanie N.","family":"Hurwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"\u00d6nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenon","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Aypar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojo S.J.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0415-2867","authenticated-orcid":false,"given":"Megan S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.modpat.2023.100170_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100170_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A\u00a0recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2023.100170_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"issue":"11","key":"10.1016\/j.modpat.2023.100170_bib5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.modpat.2023.100170_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2017.186","article-title":"A\u00a0comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration","volume":"31","author":"Rymkiewicz","year":"2018","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2023.100170_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2023.100170_bib8","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.modpat.2023.100170_bib9","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A\u00a0biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib10","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","article-title":"Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma","volume":"105","author":"Wagener","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2023.100170_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263980","article-title":"Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature","volume":"17","author":"Woroniecka","year":"2022","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.modpat.2023.100170_bib12","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2023.100170_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","article-title":"A\u00a0Diagnostic approach to the identification of Burkitt-like lymphoma with 11q aberration in aggressive B-cell lymphomas","volume":"45","author":"Horn","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100170_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100170_bib16","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.modpat.2023.100170_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41379-021-00950-3","article-title":"Transcriptome and unique cytokine microenvironment of Castleman disease","volume":"35","author":"Wing","year":"2022","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100170_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100170_bib20","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.modpat.2023.100170_bib21","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"7418","key":"10.1016\/j.modpat.2023.100170_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.modpat.2023.100170_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.modpat.2023.100170_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-019-0637-7","article-title":"A\u00a0modular transcriptome map of mature B cell lymphomas","volume":"11","author":"Loeffler-Wirth","year":"2019","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib25","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3324\/haematol.2018.198572","article-title":"Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"104","author":"Evrard","year":"2019","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.modpat.2023.100170_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"issue":"14","key":"10.1016\/j.modpat.2023.100170_bib27","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.3390\/cancers14143434","article-title":"Classifying germinal center derived lymphomas-navigate a complex transcriptional landscape","volume":"14","author":"Loeffler-Wirth","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2023.100170_bib28","first-page":"448","article-title":"A\u00a0new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas","volume":"56","author":"Meerabux","year":"1996","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.modpat.2023.100170_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100170_bib30","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer\u2013binding factor 1 expression is characteristic for sporadic Burkitt\u2019s lymphoma","volume":"182","author":"Walther","year":"2013","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100170_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125429","article-title":"Characterization of LEF1 high expression and novel mutations in adult acute lymphoblastic leukemia","volume":"10","author":"Guo","year":"2015","journal-title":"PloS ONE"},{"issue":"24","key":"10.1016\/j.modpat.2023.100170_bib32","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1182\/blood-2011-04-350850","article-title":"Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia","volume":"118","author":"K\u00fchnl","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2023.100170_bib33","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1182\/bloodadvances.2021004635","article-title":"Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma","volume":"5","author":"Gebauer","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.modpat.2023.100170_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergen.2015.12.005","article-title":"The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma","volume":"209","author":"Havelange","year":"2016","journal-title":"Cancer Genet"},{"issue":"1","key":"10.1016\/j.modpat.2023.100170_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like lymphoma with 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2017","journal-title":"Am J Clin Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:24:07Z","timestamp":1760232247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0893395223000753"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100170","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100170"}}